Literature DB >> 30277595

Association between chronic viral hepatitis and metabolic syndrome in southern Taiwan: a large population-based study.

Yuan-Hung Kuo1,2, Kwong-Ming Kee1, Jing-Houng Wang1, Nien-Tzu Hsu1,3, Chang-Chun Hsiao2,4, Yi Chen5, Sheng-Nan Lu1,2,6.   

Abstract

BACKGROUND: The impact of metabolic syndrome (MetS) on hepatitis is an interesting issue. AIM: To evaluate the association of MetS and chronic viral hepatitis including hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in southern Taiwan.
METHODS: From 2004 to 2013, a series of community-based health screenings for residents aged 40 and older were held in Tainan city. MetS was defined according to the Joint Scientific Statement. Cut-offs of body-mass index measures of 24 kg/m2 and 27 kg/m2 were used to stratify lean, overweight and obese subjects.
RESULTS: We enrolled 180 359 participants; the prevalence of MetS was 30.1%, which was significantly associated with advanced age and female sex. There were 18 726 (10.4%) HBV, 13 428 (7.4%) HCV, 1337 (0.7%) HBV plus HCV (B+C) and 146 868 (81.5%) non-HBV non-HCV participants (NBNC). Prevalence rates of MetS in subjects with HBV, HCV, B+C and NBNC were 25.2%, 31.5%, 28.9% and 30.7% respectively (P < 0.001). There were 18.8% lean body, 35.4% overweight and 45.8% obese participants among 54 361 MetS subjects. Lean MetS subjects were older, had more diabetes, and had higher metabolic component levels, but lower alanine transaminase and aspartate transaminase-platelet ratio index levels compared with obese MetS subjects. HCV infection was positively associated with MetS (P < 0.001). However, HBV infection was inversely associated with MetS only among lean subjects (P = 0.002), but not among the general population.
CONCLUSIONS: This large population-based study indicated that HCV infection was positively associated with MetS. However, HBV infection was inversely associated with MetS only among lean subjects.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  body mass index; community study; hepatitis B virus; hepatitis C virus; metabolic syndrome

Mesh:

Year:  2018        PMID: 30277595     DOI: 10.1111/apt.14960

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

1.  Analysis Of Risk Factors For Nonalcoholic Fatty-Liver Disease In Hepatitis B Virus Infection: A Case-Control Study.

Authors:  Ghodsiyeh Azarkar; Zahra Doosti; Freshteh Osmani; Masood Ziaee
Journal:  Hepat Med       Date:  2019-10-25

Review 2.  Chronic hepatitis B-associated liver disease in the context of human immunodeficiency virus co-infection and underlying metabolic syndrome.

Authors:  Edina Amponsah-Dacosta; Cynthia Tamandjou Tchuem; Motswedi Anderson
Journal:  World J Virol       Date:  2020-12-15

Review 3.  [Hepatitis B and C: mechanisms of virus-induced liver pathogenesis and tumorigenesis].

Authors:  Mirco Glitscher; Eberhard Hildt; Daniela Bender
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2022-01-11       Impact factor: 1.513

4.  Alanine aminotransferase to aspartate aminotransferase ratio and hepatitis B virus on metabolic syndrome: a community-based study.

Authors:  Ming-Shyan Lin; Huang-Shen Lin; Ming-Ling Chang; Ming-Horng Tsai; Yung-Yu Hsieh; Yu-Sheng Lin; Meng-Shu Tsai; Chia-Ling Yang; Mei-Yen Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-29       Impact factor: 6.055

5.  Effects of Positive Hepatitis B Core Antibody and Metabolic Disorders in Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus.

Authors:  Hae Lim Lee; Si Hyun Bae; Jaejun Lee; Pil Soo Sung; Sung Won Lee; Jeong Won Jang; Jungmin Lee; Jong Young Choi; Nam Ik Han; Seung Kew Yoon
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

6.  The Impact of Hepatitis C Virus, Metabolic Disturbance, and Unhealthy Behavior on Chronic Kidney Disease: A Secondary Cross-Sectional Analysis.

Authors:  Po-Chang Wang; Yi-Fang Wu; Ming-Shyan Lin; Chun-Liang Lin; Ming-Ling Chang; Shih-Tai Chang; Tzu-Chieh Weng; Mei-Yen Chen
Journal:  Int J Environ Res Public Health       Date:  2022-03-17       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.